Delivery Order SPE2DB22D9353-SPE2DB24FX2BV

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $3,585.06 contract is for the supply of PEDVAXHIB vaccine vials to support the medical needs of military healthcare facilities. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of prescription drugs, over-the-counter medications, biologics, and medical consumables to the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,784.00 firm fixed-price contract is to provide the PEDVAXHIB vaccine in 0.5 ml vials to fulfill the recurring pharmaceutical supply needs of military health facilities. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The order is for the PEDVAXHIB vaccine in 0.5mL vials, with a potential value of $1,751.40 and a completion date of February 23, 2024. DMS Pharmaceutical Group holds a broader indefinite delivery contract, SPE2DB, with DLA valued at up to $4,999,999 through 2025, which enables DLA to...
This federal contract award, with ID SPE2DB20D9135|SPE2DB24FZW58, is for the delivery of the PEDVAXHIB vaccine vial (0.5ml) to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $7,784.00 and is a firm fixed-price delivery order, with no set-aside designation. The prime contractor, DMS Pharmaceutical Group Inc., is a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. holds a significant...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division of the Department of Defense. The $1,282.40 order is for the supply of PEDVAXHIB 0.5ML 10S, a pharmaceutical product, with a period of performance through May 29, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the PEDVAXHIB vaccine in 0.5 mL vials. The delivery order has a potential value of $1,190.58 and a completion date of February 21, 2024. This delivery order is part of DMS Pharmaceutical Group's larger indefinite delivery contract 4600082013 with the Defense Logistics Agency, valued up to $4,999,999 through 2025, which allows the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of PEDVAXHIB vaccine vials, with a potential value of $1,167.60 and a completion date of February 16, 2024. The contract is not designated as a set-aside. It is issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDV)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of PEDVAXHIB vaccine vials in 0.5 ml doses, with a ceiling value of $5,838.00 and an ultimate completion date of August 15, 2024. The contract is not set-aside and is part of a larger indefinite delivery contract (IDC) vehicle held by DMS...
DMS Pharmaceutical Group Inc. has been awarded a nine hundred sixty-nine dollar firm fixed price delivery order against an unidentified contract vehicle to supply PEDVAXHIB vaccine vials to the Defense Logistics Agency. The delivery order has a place of performance in Park Ridge, Illinois and requires completion by August 11, 2023. No set-aside provisions were applied to this award to supply the Defense Health Agency with the pediatric Haemophilus influenzae type b vaccine. DMS Pharmaceutical...
The Defense Logistics Agency Troop Support Medical awarded a $775 delivery order to DMS Pharmaceutical Group Inc. for 4561519306 PEDVAXHIB vaccine vials in 0.5mL quantities. The firm fixed price order is for delivery to a location in Park Ridge, Illinois, with performance required between July 13-14, 2023. No additional details were provided on the original solicitation or whether this award was issued against an existing government-wide acquisition contract or other vehicle. DMS...
  • SPE2DB22D9353
    Indefinite Delivery Contract
  • SPE2DB22D9353-SPE2DB24FX2BV
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,502.80 firm fixed-price delivery order is for the supply of PEDVAXHIB vaccine vials, with a performance period ending on July 31, 2024. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with DLA under the SPE2DB program. The IDC allows DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. As a woman-owned small business, DMS Pharmaceutical Group does not have a set-aside designation for this specific delivery order.

Generated 10/29/24, 9:19 AM